1. Ang A, Loke PCW, Campbell AV, Chong SA. Live or Let Die: Ethical Issues in a Psychiatric Patient with End-stage Renal Failure. Annals Academy of Medicine, Singapore. 38(4): 370-374.
2. Bajaj V, Sengupta S, Gupta DK. Psychopathology, insight and compliance in schizophrenia. Irish Journal of Psychological Medicine. 26(1).
3. Brickell A, Nicholls TL, Procyshyn RM, McLean C, Dempster RJ, Lavoie JAA, Sahlstrom JK, Tomita TM, Wang E. Patient Safety in Mental Health. Edmonton, Alberta: Canadian Patient Safety Institute and Ontario Hospital Association.
4. Broekman BF, Chan YH, Chong YS, Quek SC, Fung D, Low YL, Ooi YP, Gluckman PD, Meaney MJ, Wong TY, Saw SM. The Influence of Birth Size on Intelligence in Healthy Children. Pediatrics. 123:1011-1016.
5. Chan WY, Chia MY, Yang GL, Woon PS, Sitoh YY, Collinson SL, Nowinski WL, Sim K. Duration of Illness, Regional Brain Morphology and Neurocognitive Correlates in Schizophrenia. Annals Academy of Medicine, Singapore. 38(5): 388-95.
6. Chee KT. Enigmas in Psychiatry. Annals Academy of Medicine, Singapore. 38(5): 447-450.
7. Chong SA, Tay AM, Subramaniam M, Pek E, Machin D. Mortality Rates Among Patients With Schizophrenia and Tardive Dyskinesia. Journal of Clinical Psychopharmacology. 29(1): 5-8.
8. Chong SA. How Clinician-Scientists Think. Annals Academy of Medicine. 38(3):260-263.
9. Chong SA, Subramaniam M, Chan YH, Chua HC, Liow PH, Pek E, Stahl D, Verma S, Chee FS. Depression Symptoms and Diabetes Mellitus in an Asian Multiracial Population. Asian Journal of Psychiatry. 2 (2):66-70.
10. Chong SA, Huxtable R, Campbell A. Authorizing Psychiatric Research: Principles, Practices and Problems. Bioethics. [Epub ahead of print]
11. Chong SA, Ong YY, Subramaniam M, Abdin E, Marx C, Campbell AV. An Assessment of Understanding and Motivations of Patients with Schizophrenia about Participating in a Clinical Trial. Contemporary Clinical Trials. 30(5):446-50.
12. Chong SA, Subramaniam M, Lee IM, Pek E, Cheok C, Verma S, Wong J. Academic Attainment: A Predictor of Psychiatric Disorder. Social Psychiatry Epidemiology. 44(11):999-1004.
13. Chong SA. Mentoring: Are We Doing It Right? Annal Academy of Medicine, Singapore. 38(7): 643-46.
14. Collinson SL, Meyyapan A, Rosenfeld JV. Injury and Recovery: Severe Amnestic Syndrome Following Traumatic Brain Injury. Brain Injury. 23(1):71-6.
15. Collinson S, Mackay CE, Jiaqing O, James ACD, Crow TJ. Dichotic Listening Impairments in Early Onset Schizophrenia are Associated with Reduced Left Temporal Lobe Volume. Schizophrenia Research. 112(1-3):24-31.
16. Collinson SL, Lim M, Chaw JH, Verma S, Sim K, Rapisarda A, Chong SA. Increased ratio of 2nd to 4th digit (2D:4D) in schizophrenia. Psychiatry Research. 176(1): 8-12.
17. Hendriks M, Mahendran R. Patient Satisfaction with Psychiatric Case Management. ASEAN Journal of Psychiatry. 10(2): July-Dec 2009.
18. Jacob R. Antipsychotic drugs and their side effects. Indian J Med Research. 129(2):208-9.
19. Jacob R, Chowdhury AN. Assessment of mental capacity in patients recruited in clinical trials in psychiatry and its relationship to informed consent. Indian J Med Ethics. 6(1)43-4.
20. Jacob R, Chowdhury AN, Jeyachandran Ganesan. Attention Deficit/Hyperactivity Disorder in Adults. Indian Journal of Medical Research. 129(4):458-60.
21. Jacob R, Chowdhury A, Kamath S, Ganesan J. Psychiatric Comorbidity in Prader-Willi Syndrome. A Case Series. German J Psychiatry 2009. 12:28-31.
22. Kheng JL, Ang LK, Ooi YP, Lim CG, Fung DSS. I Think, Therefore I Learn to Read: A Cognitive-Based Approach to Remediating Decoding Difficulties in Learning Disabled Children in Singapore. Journal of Youth Studies. 12(2) (Serial No. 24).
23. Kumar D, Saaraswat T, Sengupta SN, Mehrotra S. Upper gastrointestinal bleeding in a patient with depression receiving selective serotonin reuptake inhibitor therapy. The Indian Journal of Pharmacology. 41(1): 51-3.
24. Lee P, Zhang MY, Hong JP, Chua HC, Chen KP, Tang SW, Chan TM, Lee MS, B Lee, Gallagher GL, Dossenbach M. Frequency of Painful Physical Symptoms With Major Depressive Disorder in Asia: Relationship With Disease Severity and Quality of Life. Journal of Clinical Psychiatry. 70(1): 83-91.
25. Liew A, Verma S, Poon LY, Edimansyah A, Subramaniam M, Vaingankar J, Chong SA. Comparing Effectiveness of Risperidone with First-Generation Antipsychotic Medications in Patients with Schizophrenia-Spectrum Disorders. Pscyhopharmacol. [Epub ahead of print]
26. Lim C, Chong SA, Keefe RSE. Psychosocial Factors in the Neurobiology of Schizophrenia: A Selective Review. Annals Academy of Medicine, Singapore. 38(50): 402-6.
27. Ng WX, Lau IY, Graham S, Sim K. Neurobiological evidence for thalamic, hippocampal and related glutamatergic abnormalities in bipolar disorder: A review and synthesis. Neuroscience and Biobehavioral Review. 33: 336-354.
28. Nyunt MSZ, Chiam PC, Kua EH, Ng TP. Determinants of mental health service use in the national mental health survey of the elderly in Singapore. Clinical Practice and Epidemiology in Mental Health. 19, 5:2.
29. Poo R, Hendriks M, Lee C, Mahendran R. Enhancing psychiatric patient care in the community with case management strategies. Singapore Nursing Journal, 36(2):35-37.
30. Qiu A, Zhong J, Graham S, Chia MY, Sim K. Combined Analyses of Thalamic Volume, Shape and White Matter Integrity in First-Episode Schizophrenia. NeuroImage. 47(4):12221-0.
31. Seng KH. Reducing Polypharmacy for elderly Psychiatric patients for Safe and High Quality Care. Qual Saf Health Care 2009. [Epub ahead of print]
32. Sim K, Su HC, Fujii S, Yang SY, Chong MY, Ungvari G, Si T, He YL, Chung EK, Chan YH, Shinfuku N, Kua EH, Tan CH, Sartorius. High-dose antipsychotic use in schizophrenia: a comparison between the 2001 and 2004 Research on East Asia Psychotropic Prescription (REAP) studies. British Journal of Clinical Pharmacology. 67(1): 110-117.
33. Sim K, Su HC, Fujii S, Yang SY, Chong MY, Si TM, He YL, Chung EK, Shinfuku N, Tan CH, Ungvari G, Baldessarini RJ. Low doses of antipsychotic drugs for hospitalized schizophrenia patients in East Asia: 2004 vs. 2001. International Journal of Neuropsychopharmacology. 12: 117-123.
34. Sim K, Guo LY, Loh D, Poon LY, Sitoh YY, Verma S, Keefe R, Collinson S, Chong SA, Heckers S, Nowinski W, Pantelis C. White Matter Abnormalities and Neurocognitive Deficits Associated with the Passivity Phenomenon in Schizophrenia: A Diffusion Tensor Imaging Study. Psychiatry Research: Neuroimaging. 172(2): 121-7.
35. Sim K, Ng BY. Con Brioso E Rigore – Understanding the Neurobiology of Schizophrenia Spectrum Disorders. Annals Academy of Medicine, Singapore. 38(5): 381-2.
36. Subramaniam M, Sum CF, Pek E, Stahl D, Verma S, Liow PH, Chua HC, Abdin E, Chong SA. Comorbid Depression and Increased Health Care Utilization in Individuals with Diabetes. General Hospital Psychiatry. 31(3): 220-4.
37. Subramaniam M, Cheok C, Lee IM, Pek E, Verma S, Wong J, Chong SA. Nicotine Dependence and Psychiatric Disorders among Young Males in Singapore. Nicotine & Tobacco Research. 11(9):1107-13.
38. Tan BL. Hybrid Transitional-Supported Employment Using Social Enterprise: a Retrospective Study. Psychiatric Rehabilitation Journal. 33(1): 53-55.
39. Tan BL. Profile of Cognitive Problems in Schizophrenia and Implications for Vocational Functioning. Australian Occupational Therapy Journal. 56(4): 220-228.
40. Vaingankar J, Mahendran R, Pek E. Psychiatry Research and Ethics: Attitudes of Mental Healthcare Professionals in Singapore. ASEAN Journal of Psychiatry. 10(1): 3-7.
41. Verma S, Sitoh YY, Ho YIL, Subramaniam M, Chan YH, Sim K, Chong SA. Hippocampal Volumes in First-Episode Psychosis. The Journal of Neuropsychiatry Clinical Neuroscience. 21(1): 24-29.
42. Verma S, Subramaniam M, Liew A, Poon LY. Metabolic Risk Factors in Drug-Naive Patients with First-Episode Psychosis. Journal of Clinical Psychiatry. 70(7):997-1000.
43. Verma S, Liew A, Subramaniam M, Poon LY. Effect of Treatment on Weight Gain and Metabolic Abnormalities in Patients with First-Episode Psychosis. Aust N Z J Psychiatry. 43(9):812-7.